Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alyftrek
Pharma
Orphan drug sales to surge past $400B in 2032: report
Despite a few recent policy wins, the orphan drug market remains vulnerable to a more scrutinizing FDA and potential pricing pressures.
Angus Liu
Mar 12, 2026 8:20am
As Vertex's pain launch gains more use, sales just missed in Q3
Nov 4, 2025 8:40am
Vertex's international sales slide with IP 'violation' in Russia
May 6, 2025 2:23pm
Looking ahead at the most anticipated drug launches of 2025
Feb 7, 2025 9:00am
Top 10 most anticipated drug launches of 2025
Jan 27, 2025 3:00am
Vertex wins FDA nod for once-daily cystic fibrosis triplet
Dec 23, 2024 10:58am
